ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Swiss specialty chemical firm Clariant says it will announce a new growth strategy early in 2018 after its recent failure to complete a $20 billion “merger of equals” with Huntsman Corp. Potential options include mergers and acquisitions, short-term portfolio rearrangement, sending cash to shareholders, a review of costs, and the pursuit of new growth opportunities, the company says. The merger with Huntsman was scuttled largely by activist investor White Tale, a 20% shareholder of Clariant, which said the deal undervalued the Swiss firm. In a response, Clariant’s management emphasizes that it continues to have the backing of many of its shareholders. It claims that White Tale’s repeated requests for Clariant to hire an investment bank to conduct a strategic review indicate that White Tale is interested in breaking up the company and selling its assets. Clariant’s management says this is not in line with its long-term vision for the company.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X